Pronounced dys-autonomic symptoms announcing a primary Sjögren’s syndrome
Submitted: 24 July 2019
Accepted: 20 May 2020
Published: 23 July 2020
Accepted: 20 May 2020
Abstract Views: 1021
PDF: 631
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- C. Grava, A. Ruffatti, O. Milanesi, M. Favaro, M. Tonello, A. Calligaro, T. Del Ross, S. Todesco, Isolated congenital heart block in undifferentiated connective tissue disease and in primary Sjögren’s syndrome: a clinical study of 81 pregnancies in 41 patients , Reumatismo: Vol. 57 No. 3 (2005)
- K. Kaynar, B. Güvercin, A. Şengör, S. Mungan, A case of Sjögren syndrome and anti-neutrophil cytoplasmic antibody-associated vasculitis , Reumatismo: Vol. 75 No. 2 (2023)
- N. Belfeki, E. Gharbi, C. Flateau, S. Diamantis, Erysipelas-like presentation of Wells’ syndrome (eosinophilic cellulitis) , Reumatismo: Vol. 71 No. 4 (2019)
- B. Isci, T.S. Gamsiz, S. Kayipmaz, O. Keskin, M.E. Tezcan, Pulmonary cavitary lesions may be one of the presenting features in Ig A nephropathy , Reumatismo: Vol. 70 No. 2 (2018)
- F. Atzeni, M.G. Marrazza, P. Sarzi-Puttini, M. Carrabba, Drug-induced lupus erythematosus , Reumatismo: Vol. 55 No. 3 (2003)
- P. Sukhadiya, P. Kumar, D.S. Meena, A. Kumar P.H., N. Vijayan, P. Garg, M.K. Garg, Unmasking of systemic lupus erythematosus in a patient with hemophagocytic lymphohistiocytosis- macrophage activation syndrome (HLA-MAS) and diffuse alveolar hemorrhage , Reumatismo: Vol. 74 No. 4 (2022)
- E. Cacace, V. Ruggiero, C. Anedda, A. Denotti, L. Minerba, G. Perpignano, Quality of life and associated clinical distress in fibromyalgia , Reumatismo: Vol. 58 No. 3 (2006)
- C. Baldini, A. Tavoni, G. Merlini, M. Sebastiani, S. Bombardieri, Primary Sjogren’s syndrome: clinical and serological feature of a single centre , Reumatismo: Vol. 57 No. 4 (2005)
- L. Altomonte, F. Atzeni, G. Leardini, A. Marsico, R. Gorla, R. Casale, G. Cassisi, S. Stisi, F. Salaffi, F. Marinangeli, M.A. Giamberardino, M. Di Franco, G. Biasi, G. Arioli, A. Alciati, F. Ceccherelli, L. Bazzichi, R. Carignola, M. Cazzola, R. Torta, D. Buskila, M. Spath, R.H. Gracely, P. Sarzi-Puttini, Fibromyalgia syndrome: preventive, social and economic aspects , Reumatismo: Vol. 60 No. s1 (2008)
- P. Sarzi- Puttini, R. Torta, F. Marinangeli, G. Biasi, M. Spath, D. Buskila, R.H. Gracely, M.A. Giamberardino, L. Bazzichi, M. Cazzola, M. Di Franco, S. Stisi, F. Salaffi, R. Casale, G. Leardini, R. Gorla, A. Marsico, R. Carignola, L. Altomonte, F. Ceccherelli, G. Cassisi, G. Arioli, A. Alciati, F. Atzeni, Fibromyalgia syndrome: the pharmacological treatment options , Reumatismo: Vol. 60 No. s1 (2008)
<< < 4 5 6 7 8 9 10 11 12 13 > >>
You may also start an advanced similarity search for this article.